ID: ALA4218639

Max Phase: Preclinical

Molecular Formula: C15H16N8OS

Molecular Weight: 356.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(N2CCN(C(=O)Nc3cccnc3)CC2)c2ncsc2n1

Standard InChI:  InChI=1S/C15H16N8OS/c16-14-20-12(11-13(21-14)25-9-18-11)22-4-6-23(7-5-22)15(24)19-10-2-1-3-17-8-10/h1-3,8-9H,4-7H2,(H,19,24)(H2,16,20,21)

Standard InChI Key:  FLEPMDMQZVIRIZ-UHFFFAOYSA-N

Associated Targets(Human)

PI4-kinase beta subunit 1593 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.42Molecular Weight (Monoisotopic): 356.1168AlogP: 1.42#Rotatable Bonds: 2
Polar Surface Area: 113.16Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.79CX Basic pKa: 4.65CX LogP: 0.87CX LogD: 0.87
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.71Np Likeness Score: -2.04

References

1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R..  (2018)  Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.,  61  (15): [PMID:29952567] [10.1021/acs.jmedchem.8b00521]

Source